Avorn J - Search Results

1

Variations in pill appearance of antiepileptic drugs and the risk of nonadherence.

Kesselheim AS, Misono AS, Shrank WH, Greene JA, Doherty M, Avorn J, Choudhry NK. Kesselheim AS, et al. Among authors: avorn j. JAMA Intern Med. 2013 Feb 11;173(3):202-8. doi: 10.1001/2013.jamainternmed.997. JAMA Intern Med. 2013. PMID: 23277164

2

Nonsteroidal anti-inflammatory drug use and acute myocardial infarction.

Solomon DH, Glynn RJ, Levin R, Avorn J. Solomon DH, et al. Among authors: avorn j. Arch Intern Med. 2002 May 27;162(10):1099-104. doi: 10.1001/archinte.162.10.1099. Arch Intern Med. 2002. PMID: 12020178

3

Long-term persistence in use of statin therapy in elderly patients.

Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Benner JS, et al. Among authors: avorn j. JAMA. 2002 Jul 24-31;288(4):455-61. doi: 10.1001/jama.288.4.455. JAMA. 2002. PMID: 12132975

4

Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized patients.

Fischer MA, Solomon DH, Teich JM, Avorn J. Fischer MA, et al. Among authors: avorn j. Arch Intern Med. 2003 Nov 24;163(21):2585-9. doi: 10.1001/archinte.163.21.2585. Arch Intern Med. 2003. PMID: 14638558

5

University-based science and biotechnology products: defining the boundaries of intellectual property.

Kesselheim AS, Avorn J. Kesselheim AS, et al. Among authors: avorn j. JAMA. 2005 Feb 16;293(7):850-4. doi: 10.1001/jama.293.7.850. JAMA. 2005. PMID: 15713775

6

Over-the-counter statins.

Choudhry NK, Avorn J. Choudhry NK, et al. Among authors: avorn j. Ann Intern Med. 2005 Jun 7;142(11):910-3. doi: 10.7326/0003-4819-142-11-200506070-00009. Ann Intern Med. 2005. PMID: 15941698

7

Compliance with osteoporosis medications.

Solomon DH, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Brookhart MA. Solomon DH, et al. Among authors: avorn j. Arch Intern Med. 2005 Nov 14;165(20):2414-9. doi: 10.1001/archinte.165.20.2414. Arch Intern Med. 2005. PMID: 16287772

8

Biomedical patents and the public's health: is there a role for eminent domain?

Kesselheim AS, Avorn J. Kesselheim AS, et al. Among authors: avorn j. JAMA. 2006 Jan 25;295(4):434-7. doi: 10.1001/jama.295.4.434. JAMA. 2006. PMID: 16434634 No abstract available.

9

The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.

Shrank WH, Hoang T, Ettner SL, Glassman PA, Nair K, DeLapp D, Dirstine J, Avorn J, Asch SM. Shrank WH, et al. Among authors: avorn j. Arch Intern Med. 2006 Feb 13;166(3):332-7. doi: 10.1001/archinte.166.3.332. Arch Intern Med. 2006. PMID: 16476874

10

Highlights and a hidden hazard--the FDA's new labeling regulations.

Avorn J, Shrank W. Avorn J, et al. N Engl J Med. 2006 Jun 8;354(23):2409-11. doi: 10.1056/NEJMp068119. N Engl J Med. 2006. PMID: 16760439 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

611 results

Search Page